| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/01/2006 | US7084163 Applying to plants |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | CA2360024C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2236851C Substituted vinylpyridine derivatives and drugs containing the same |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006078621A2 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 07/27/2006 | WO2006077387A2 Novel benzamide derivatives |
| 07/27/2006 | WO2006077168A1 Pyrazolopyridines, their preparation and their medical use |
| 07/27/2006 | WO2006076821A1 2 -c-substituted propane-1, 3 -dicarbonyl compounds and their use in neutralising malodour |
| 07/27/2006 | WO2006050480A3 Substituted pyridines with activity on syk kinase |
| 07/27/2006 | WO2006034333A3 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 07/27/2006 | WO2006008316A3 Selective inhibitors of human corticosteroid syntheses |
| 07/27/2006 | WO2005117904A3 Phosphonate analogs of hiv integrase inhibitor compounds |
| 07/27/2006 | WO2005100381A3 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 07/27/2006 | US20060167315 N-(aminosulfonylalkylene)-N'-(phenyl-or pyridyl)phthalamide derivatives, e.g., N2-(2-ethylsulfamoyl-1-methylethyl)-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide; is effective even at low dosage |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167264 Pyridine-3-sulfonyl compounds as pesticidal agents |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167061 Removing a OH, Cl, Br, mesyl, or tosyl group from the 2-position on the ethoxy of 5-[4-[2-(alkyl substituted pyridyl)ethoxy]benzyl-2,4-thiazolidinedione by reaction with a zinc or acetic acid reducing agent in an alcoholic solvent |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166989 2-naphthamide derivatives |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166946 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/27/2006 | US20060166033 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 07/27/2006 | US20060165916 Cyanopyridone derivatives as liquid crystals |
| 07/27/2006 | US20060165548 Method for producing a moulded body from sintered steel |
| 07/27/2006 | DE4238377B4 Flüssigkristallines Medium Liquid-crystalline medium |
| 07/26/2006 | EP1683804A2 Platinum complex and luminescent element |
| 07/26/2006 | EP1683788A1 The derivatives of pyridone and the use of them |
| 07/26/2006 | EP1683787A1 Method for producing bactericidal pyridine compound and bactericidal pyridine compound |
| 07/26/2006 | EP1682509A1 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 07/26/2006 | EP1682508A1 Phenyl derivatives as ppar agonists |
| 07/26/2006 | EP1682507A1 Benzannelated compounds as ppar activators |
| 07/26/2006 | EP1682494A1 Aralkyl amines as cannabinoid receptor modulators |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1681924A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 07/26/2006 | EP1359905B1 Use of mglur5 antagonists for the treatment of pruritic conditions |
| 07/26/2006 | EP0801527B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 07/26/2006 | CN1809571A Fungicidal triazolopyrimidines. |
| 07/26/2006 | CN1809536A Inhibitors of Akt activity |
| 07/26/2006 | CN1809530A Haloalkyl containing compounds as cysteine protease inhibitors |
| 07/26/2006 | CN1807691A Method and apparatus for electrolytic synthesis of 3,6-dichloropyridine-carboxylic acid |
| 07/26/2006 | CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 07/26/2006 | CN1807415A 4-aminopyridine preparation method |
| 07/26/2006 | CN1807414A 2,3-dichloropyridine synthesis method |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1266133C Process for preparing acetyl substituted nitrogen-containing heterocyclic compound |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/26/2006 | CN1266117C Process for preparation of alpha-hydroxycarboxylic acid amides |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/26/2006 | CN1266098C Substituted dicyclohexylalkyl diphenyl derivative with good low-temperature, mutual solubility, its preparation and application |
| 07/26/2006 | CN1265792C Use of niacin alkyl ester containing alkyl chain with 8 to 22 carbon atom in preparation of medicine for increasing leptin |
| 07/25/2006 | US7081535 omega-carboxy-2-hydroxy- ethyl- or propyl-amines, 1-substituted with thienyl, phenyl, pyridyl, allyl or propargyl; used in synthesis of pharmaceuticals |
| 07/25/2006 | US7081524 O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081467 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/25/2006 | US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/25/2006 | CA2263328C Use of .gamma.-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
| 07/25/2006 | CA2168921C 1,6-naphthyridonecarboxylic acid derivatives |
| 07/25/2006 | CA2135888C Pyridinium intermediates and the process for preparing the same |
| 07/25/2006 | CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006076630A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 |
| 07/20/2006 | WO2006076511A1 N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide crystalline form 1 |
| 07/20/2006 | WO2006075748A1 Therapeutic agent for allergic conjunctival disease |
| 07/20/2006 | WO2006075160A1 N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer |
| 07/20/2006 | WO2006075159A1 Anti-bacterial compounds |
| 07/20/2006 | WO2006074797A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | WO2006074501A1 Peptidic compounds |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160865 Pyridinyl carbamates |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160820 Substituted piperazine carbamates |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160812 1-Substituted-3,5-distyrylpyrazoles; protect neurons and promote neuroregeneration and memory formation; treatments for acute neural injuries (such as stroke and spinal cord injury) and chronic neurodegenerative diseases |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | DE19507822B4 Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel Substituted DTPA-monoamides of central carboxylic acid and their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics and therapy and methods for preparing the complexes and agents |
| 07/20/2006 | DE102005000858A1 Use of trifluoromethoxy- or pentafluorosulfuranyl terminal groups as hydrophobic terminal groups in surface active compounds, which are useful as e.g. surfactants, hydrophobic agents, foam stabilizers and emulsifying agents |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |